Humana’s Medicare insulin benefit is getting even better in 2023

Humana Medicare members will pay $35 or less for a 1-month (up to a 30 day) supply of insulin. This will begin on Jan. 1, 2023. Members with Medicare Advantage Prescription Drug (MAPD) or Medicare Part D Prescription Drug Plans (PDP) all qualify for the benefit.

Here is some additional information about your new insulin benefits that may not be described in your current Humana plan materials:

• You will pay $35 or less for a 30-day supply of insulin covered by your plan, no matter which cost-sharing tier the insulin is in
• The benefit begins day 1 of your plan start date
• The benefit applies throughout the entire year, even if you haven’t met your deductible
• All Medicare members are eligible even if you qualify for the Low-Income Subsidy available under the Medicare Part D prescription drug program, including those who receive “Extra Help”

Learn more about your enhanced Medicare benefits, such as insulin benefits, on the Inflation Reduction Act webpage.

If you have a Humana MAPD or Humana Premier Rx Plan™ (PDP) with Humana’s Insulin Savings Benefit, you will continue to receive affordable, predictable costs on Select Insulins. See if your insulin qualifies by reviewing Humana’s Select Insulin List, PDF.

The Insulin Savings Benefit is part of the Part D Senior Savings Model from the Centers for Medicare and Medicaid Services (CMS).